文献速递心胸血管麻醉

心脏手术后术中低血压阈值与新发肾脏替代治疗的关联

Defining an Intraoperative Hypotension Threshold in Association with De Novo Renal Replacement Therapy after Cardiac Surgery.
PubMed 文献 · Anesthesiology · 2020-01-01

结果显示,体外循环后平均动脉压低于65 mmHg持续10分钟以上与新发肾脏替代治疗风险增加相关,而体外循环前和期间的低血压未显示关联。

要点

  • 体外循环后MAP低于55 mmHg每10分钟,肾脏替代治疗风险增加13%。
  • 体外循环后MAP 55-64 mmHg每10分钟,肾脏替代治疗风险增加12%。
  • 体外循环前和期间的低血压与新发肾脏替代治疗无显著关联。

核心结论

  • 体外循环后平均动脉压低于65 mmHg持续10分钟以上与新发术后肾脏替代治疗风险增加相关。

主要发现

  • 336例(5.2%)需要新发术后肾脏替代治疗。
  • 体外循环后MAP低于55 mmHg每10分钟纪元,调整OR为1.13(95%CI 1.05-1.23;P=0.002)。
  • 体外循环后MAP 55-64 mmHg每10分钟纪元,调整OR为1.12(95%CI 1.06-1.18;P=0.0001)。
  • 体外循环前和期间的低血压与肾脏替代治疗无关联。

关键数值与推荐

  • 低血压定义为MAP低于55、55-64、65-74 mmHg,分体外循环前、中、后三个时段。
  • 主要结局为新发术后肾脏替代治疗。

临床怎么用

  • 心脏手术后应关注体外循环后平均动脉压,避免低于65 mmHg持续10分钟以上。

局限性

  • 单中心回顾性设计。
  • 排除透析依赖、胸主动脉或非体外循环手术及未接受肾脏替代治疗即死亡的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Acute kidney injury (AKI) is a frequent and deadly complication after cardiac surgery. In the absence of effective therapies, a focus on risk factor identification and modification has been the mainstay of management. The authors sought to determine the impact of intraoperative hypotension on de novo postoperative renal replacement therapy in patients undergoing cardiac surgery, hypothesizing that prolonged periods of hypotension during and after cardiopulmonary bypass (CPB) were associated with an increased risk of renal replacement therapy. METHODS: Included in this single-center retrospective cohort study were adult patients who underwent cardiac surgery requiring CPB between November 2009 and April 2015. Excluded were patients who were dialysis dependent, underwent thoracic aorta or off-pump procedures, or died before receiving renal replacement therapy. Degrees of hypotension were defined by mean arterial pressure (MAP) as less than 55, 55 to 64, and 65 to 74 mmHg before, during, and after CPB. The primary outcome was de novo renal replacement therapy. RESULTS: Of 6,523 patient records, 336 (5.2%) required new postoperative renal replacement therapy. Each 10-min epoch of MAP less than 55 mmHg post-CPB was associated with an adjusted odds ratio of 1.13 (95% CI, 1.05 to 1.23; P = 0.002), and each 10-min epoch of MAP between 55 and 64 mmHg post-CPB was associated with an adjusted odds ratio of 1.12 (95% CI, 1.06 to 1.18; P = 0.0001) for renal replacement therapy. The authors did not observe an association between hypotension before and during CPB with renal replacement therapy. CONCLUSIONS: MAP less than 65 mmHg for 10 min or more post-CPB is associated with an increased risk of de novo postoperative renal replacement therapy. The association between intraoperative hypotension and AKI was weaker in comparison to factors such as renal insufficiency, heart failure, obesity, anemia, complex or emergent surgery, and new-onset postoperative atrial fibrillation. Nonetheless, post-CPB hypotension is a potentially easier modifiable risk factor that warrants further investigation.

来源:Anesthesiology,查看原文。版权归原作者所有。

引用

  1. Ngu JMC, Jabagi H, Chung AM, et al. Defining an Intraoperative Hypotension Threshold in Association with De Novo Renal Replacement Therapy after Cardiac Surgery. Anesthesiology. 2020. PMID: 32205546. doi:10.1097/ALN.0000000000003254

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。